Carbapenem-based Antibiotics Market Global Growth, OpportunitiesPosted by Preet on February 18th, 2020 Increase in prevalence of bacterial infection across the globe as become an opportunity for many. It generates lucrative option for revenue generation for the stake holders in carbapenem-based antibiotics market. These antibiotics are used to treat diseases like pneumonia which exists because of varied reasons. It can be developed due to multiple reasons like prolonged hospital stay and side effects of medical conditions like organ transplant and Cancer. It has the potential to deter the efficacy of any ongoing treatment and is fatal at times. Pneumonia is considered to be difficult to treat and carbapenem-based antibiotics have found to be effective in treatment. Open surgeries induce bacterial infections Center for disease control states that patients who have been admitted in hospital because of various reasons like treatment of immunosuppressive disease and side effects of improper infection control treatment have the tendency to develop pneumonia which is hospital-acquired. Apart from this pneumonia, different types of diseases induced by bacteria have high prevalence which propel the global market for carbapenem-based antibiotics. Open surgeries are required during the treatment of many chronic health conditions. Carbapenem-based antibiotics are administered as a preventive measure ahead of such surgeries to prevent any changes of bacterial infections post-surgery. World Health organization stresses on protocols for controlling infections. World Health Organization indicates that 30% of the total diseases acquired across the globe are induced as post-surgery impact. This data also significantly surges the demand for carbapenem-based antibiotics. The business intelligence study of the carbapenem-based antibiotics market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the carbapenem-based antibiotics market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the carbapenem-based antibiotics market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4425 The key players in the global carbapenem-based antibiotics market report consist of
Each market player encompassed in the carbapenem-based antibiotics market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the carbapenem-based antibiotics market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis. Patent expiry is a challenge Patent expiry is a challenge before global market. Ertapenem is considered to be most extensively used antibiotic which is based on carbapenem but its patent expired in the end of the year 2017. Different players on regional as well as global level acknowledged the gap created in the market by expiry of this product. They are busy launching medicines that are the generic forms of Ertapenem. Aurobindo Pharma is one of the major stake holders that launched its generic version named Invanz injection which also received acceptance for FDA. It is an antibiotic which is based on carbapenem. It sis jointly created by Dohme Corp. and Merck Sharp and is used in treatment of a wide range of bacterial infections. Carbapenem-based antibiotics’ generic versions have been launched in regions like Europe and North America which generates great amount of revenue in global market. Low prices of generic products works in favor of stake holders. Low prices promotes their adoption as they are affordable by larger population segment. Manufacturers have recognized this trend and are currently striving to strengthen their market presence in generic medicines which is extensively used by low and medium income groups. Regions like North America, Europe and East Asia are witnessing surge in supply chain operators which results in greater revenue generation in global market. On the basis of product type, the global carbapenem-based antibiotics market report covers the footprint, and consumption of the segments including
The global carbapenem-based antibiotics market covers the demand trends of indications which includes
What insights readers can gather from the carbapenem-based antibiotics market report?
The carbapenem-based antibiotics market report answers the following queries:
Why Choose Fact.MR?
Like it? Share it! More by this author |